Objective
To describe the characteristics of patients who undergo total artificial heart support and to explore the ethical aspects of its withdrawal.
Patients and Methods
We retrospectively reviewed the medical records of all adult recipients of total artificial heart at our institution from the program’s inception in 2007 to June 30, 2015. Management of other life-sustaining therapies, approach to end-of-life decision making, engagement of ethics and palliative care consultation, and causes of death were analyzed.
Results
Of 47 total artificial heart recipients, 14 patients or their surrogates (30%) requested withdrawal of total artificial heart support. No request was denied by treatment teams. All 14 patients were supported with at least 1 other life-sustaining therapy. Only 1 patient was able to participate in decision making.
Conclusion
It is widely held to be ethically permissible to withdraw a life-sustaining treatment when the treatment no longer meets the patient’s health care–related goals (ie, the burdens outweigh the benefits). Our data suggest that some patients, surrogates, physicians, and other care providers believe that this principle extends to the withdrawal of total artificial heart support.